Bristol-Myers Squibb Co.

NYSE:BMY  
64.92
+0.32 (+0.50%)
Earnings Announcements

Evotec Expands Neuroscience Collaboration With Bristol Myers Squibb

Published: 01/11/2022 06:39 GMT
Bristol-Myers Squibb Co. (BMY) - Dgap-news: Evotec Expands Neuroscience Collaboration With Bristol Myers Squibb to Include New Targeted Protein Degradation Approach.
Evotec Receives Payments Totalling Us$ 15 M From Bristol Myers Squibb.
Focus Will Be on Selected Targets That Are Relevant to a Range of Neurodegenerative Conditions.
Further Company Coverage: .
((frankfurt.
Newsroom@thomsonreuters.
Com;)).
Revenue is expected to be $12.11 Billion
Adjusted EPS is expected to be $1.82

Next Quarter Revenue Guidance is expected to be $11.88 Billion
Next Quarter EPS Guidance is expected to be $2.02

More details on our Analysts Page.